The Drug Landscape team

Drug Landscape is built and edited by a small team with backgrounds in pharma data engineering, drug discovery, and health economics. We work in public — every claim on the site is sourced from primary regulatory and clinical-trial sources (see editorial policy).

How decisions get made

• Data ingest — automated pipelines pull from FDA DailyMed, ClinicalTrials.gov, EMA, NICE, SEC, USPTO, CMS NADAC, NHS BSA, PubMed.
• Verification — every drug profile passes a 4-point quality gate (mechanism, indications, safety, trials) before it's exposed to search results or AI endpoints.
• Editorial review — anomalies and reader-flagged errors are triaged within 5 business days. Corrections are logged with a visible date stamp.
• AI grounding — every LLM-assisted output is grounded in primary-source data. We never ask the model to recall from training; we feed it the verified record and ask it to format or summarise.

Contact

• Editorial corrections: hello@druglandscape.com
• API + data licensing: hello@druglandscape.com
• Security disclosure: security@druglandscape.com (or see /.well-known/security.txt)

How we're funded

User subscriptions (Pro / Team) and bulk data licensing. We are not funded by, owned by, or operated on behalf of any pharmaceutical manufacturer, regulator, or HTA body. No data point is influenced by sponsorship.

Standards we follow

• Schema.org structured data on every entity page
• OpenAPI 3.1 for the public API (/.well-known/openapi.json)
• RSS 2.0 + Atom 1.0 + JSON Feed 1.1 for the blog (feed)
• IndexNow for instant search-engine submission
• RFC 9116 security.txt
• OpenSearch 1.1 description (opensearch.xml)